fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

Promising Results of a Pilot Trial at Sheba to Test New Palliative Care Techniques

Palliative Care Techniques
There is a pressing need for new approaches to pain management that do not involve the risky realm of addictive opioids and nerve blocks. In response, a clinical trial to test a new palliative care technique for patients with upper abdominal cancer is underway at Sheba Medical Center – and the significant results are encouraging.
Dr. Yaacov-Richard Lawrence researched and tested the latest Palliative Care Techniques
Dr. Yaacov Lawrence

“Palliative care is so incredibly important for our patients,” said Dr. Yaacov Lawrence, Director of the Center for Translational Radiation Oncology at Sheba. “It improves their quality of life and gives them tremendous hope. We are thrilled with the results of this pilot and are eager to keep moving forward so that we can help as many patients as possible find relief.”

The innovative technique, celiac plexus radiosurgery, involves targeting a single dose of radiation at the celiac plexus – nerves located behind the pancreas at the 12th thoracic vertebrae. Over 80% of the participants in the first phase of the trial reported substantial reductions in pain, and one-third of the participants claimed that all their pain was resolved.

The Sheba study is testing the efficacy and safety of this palliative therapy, and it has attracted much attention. Within the first year, over 23 patients enrolled in the trial. Currently, 100 patients have enrolled in the next phase of the Celica Plexus Radiosurgery Clinical Trial, which will be conducted by Dr. Lawrence, Dr. Tikva Meron, RN PhD, and their Tel Aviv team in conjunction with researchers from London, Philadelphia, Ohio, and Toronto. The trial, which is funded by Gateway for Cancer Research, will also expand to additional medical centers in North America, Europe, and the Middle East.

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More